Codes / ICD10CM / C82.51

C82.51 Diffuse follicle center lymphoma, lymph nodes of head, face, and neck

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Diffuse Follicle Center Lymphoma, Lymph Nodes of Head, Face, and Neck

Summary

Diffuse follicle center lymphoma is a type of non-Hodgkin lymphoma that originates in the lymphatic system, specifically affecting B-cells. It is characterized by the proliferation of cancerous lymphocytes, which can accumulate in lymph nodes and other tissues. This condition may present with varying clinical behavior, ranging from indolent to more aggressive forms. When localized to the lymph nodes of the head, face, and neck, it typically involves the cervical, facial, or other regional lymph node groups in this area.

Causes

The exact cause of diffuse follicle center lymphoma is not fully understood, but it is associated with genetic mutations in B-cells. Environmental factors and immune system dysfunction may contribute to its development.

Risk Factors

  • Age: More common in individuals over 60.
  • Family history: A history of lymphoma can increase risk.
  • Immune system deficiencies.
  • Certain infections, such as hepatitis C.

Symptoms

  • Painless swelling of lymph nodes in the head, face, or neck.
  • Fatigue.
  • Night sweats.
  • Unexplained weight loss.
  • Fever.

Diagnosis

Diagnosis involves a physical examination, medical history review, blood tests, imaging studies (e.g., CT or PET scans), and a biopsy of affected lymph nodes to confirm the presence and subtype of lymphoma. The biopsy helps determine if the lymphoma is localized to the head, face, or neck region.

Treatment Options

  • Watchful waiting: Monitoring the condition without immediate treatment if symptoms are mild.
  • Radiation therapy: Targeted treatment for localized disease in the head, face, or neck.
  • Chemotherapy: Systemic treatment to kill cancer cells, especially if the disease is more widespread.
  • Immunotherapy: Enhancing the immune system to target cancer cells.

Prognosis and Follow-Up

Prognosis depends on the stage, grade, and response to treatment. Regular follow-up with imaging and blood tests is essential to monitor for recurrence or progression. Early detection and appropriate management can improve outcomes.

Complications

  • Spread to other lymph node regions or organs.
  • Infection due to weakened immune system.
  • Treatment-related side effects, such as fatigue or nausea.

Lifestyle & Prevention

  • Maintain a healthy immune system through balanced nutrition and regular exercise.
  • Avoid known risk factors, such as smoking or excessive alcohol consumption.
  • Stay up-to-date with vaccinations to reduce infection risk.

When to Seek Professional Help

Seek medical attention if you experience persistent, painless lymph node swelling in the head, face, or neck, or unexplained symptoms like night sweats or weight loss.

Tips for Medical Coders

Use code C82.51 for diffuse follicle center lymphoma specifically involving the lymph nodes of the head, face, and neck. Ensure documentation specifies the anatomical location to support accurate coding. Verify that the diagnosis aligns with histopathological confirmation and clinical findings.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

C82.51 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.